Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients

BackgroundPatients with hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (mPVTT) have poor prognosis. Promising systemic therapies, such as target therapies, have limited benefits. The purpose of this study is to retrospectively evaluate the benefits of conventional TACE (c-TACE)...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Jing-huan Li, Xin Yin, Wen-shuai Fan, Lan Zhang, Rong-xin Chen, Yi Chen, Li-xin Li, Ning-ling Ge, Yu-hong Gan, Yan-hong Wang, Zheng-gang Ren
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2021-08-01
Serie:	Frontiers in Oncology
Soggetti:	hepatocellular carcinoma (HCC) portal vein tumor thrombus (PVTT) transarterial chemoembolization (TACE) overall survival (OS) prognosis model
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2021.671171/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!